Showing results (71-80 of 85) with videos related to
Sort By:
Pageof 9
Scientific Reports|March 19, 2021
Confirmation of the cardiac safety of nolasiban in a randomised cohort of healthy female volunteersJörg Täubel, Ulrike Lorch, Christopher S Spencer, et al.Journal of Clinical Pharmacology|July 2, 2021
Electrophysiological and ECG Effects of Perhexiline, a Mixed Cardiac Ion Channel Inhibitor, Evaluated in Nonclinical Assays and in Healthy SubjectsMark G Midei, Borje Darpo, Greg Ayers, et al.Journal of Clinical Pharmacology|October 23, 2019
Effects of the Fluoroquinolones Moxifloxacin and Levofloxacin on the QT Subintervals: Sex Differences in Ventricular RepolarizationJӧrg Täubel, Krishna Prasad, Giuseppe Rosano, et al.Journal of Clinical Pharmacology|January 12, 2019
The Cardiovascular Effects of a Meal: J-T<sub>peak</sub> and T<sub>peak</sub> -T<sub>end</sub> Assessment and Further Insights Into the Physiological EffectsJörg Täubel, Georg Ferber, Leen Van Langenhoven, et al.Journal of Pharmacokinetics and Pharmacodynamics|January 14, 2018
Correction to: Scientific white paper on concentration-QTc modelingChristine Garnett, Peter L Bonate, Qianyu Dang, et al.Cancer Chemotherapy and Pharmacology|April 1, 2018
Effect of ulixertinib, a novel ERK1/2 inhibitor, on the QT/QTc interval in patients with advanced solid tumor malignanciesBoaz Mendzelevski, Georg Ferber, Filip Janku, et al.British Journal of Clinical Pharmacology|June 2, 2021
Concentration-QT modelling of the novel DHFR inhibitor P218 in healthy male volunteersJӧrg Täubel, Ulrike Lorch, Georg Ferber, et al.Journal of Pharmacokinetics and Pharmacodynamics|December 7, 2017
Scientific white paper on concentration-QTc modelingChristine Garnett, Peter L Bonate, Qianyu Dang, et al.Clinical Pharmacology in Drug Development|May 4, 2021
A Phase 1 Study to Investigate the Effects of Cortexolone 17α-Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay SensitivityJörg Täubel, Alessandro Mazzetti, Georg Ferber, et al.Journal of Clinical Pharmacology|June 6, 2022
ECG Evaluation as Part of the Clinical Pharmacology Strategy in the Development of New Drugs: A Review of Current Practices and Opportunities Based on Five Case StudiesBorje Darpo, Marie Borin, Georg Ferber, et al.Pageof 9